Cardiotoxicity in Non-metastatic Lung Cancer Patients Treated with Chemoradiation Therapy: A Prospective Longitudinal Cohort
Recruiting
99 years and younger
All
Phase
N/A
100 participants needed
1 Location
Brief description of study
We propose a prospective longitudinal cohort of radiation therapy cardiotoxicity in in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiation. We will enroll patients prior to start of chemoradiation and follow them with echocardiogram, PET/CT stress test, blood draw, and symptoms/activity surveys for 2 years to determine if radiation therapy results in early, sub-clinical cardiovascular dysfunction, to understand how cardiac dose-volume parameters influence these abnormalities, and to develop multi-marker strategies in risk prediction.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Lung Cancer
-
Age: - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 834810
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
